Ultragenyx Pharmaceutical reported a gross margin of 84.11% and a net margin of -42.99% for the quarter ended Jun 2026. These financial ratios cover 52 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2013 | Jun2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 94.89% | 95.79% | 92.37% | 90.74% | 90.48% | 94.85% | 87.80% | 90.85% | 88.79% | 90.69% | 83.89% | 85.53% | 84.93% | 89.57% | 79.14% | 86.23% | 82.50% | 85.84% | 77.94% | 84.11% | ||||||||||||||||||||||||||||||||
| EBT Margin | -89.18% | -149.63% | -189.86% | -176.69% | -263.30% | -149.95% | -162.67% | -146.89% | -162.16% | -100.22% | -156.41% | -88.92% | -95.50% | -80.67% | -107.91% | -68.26% | -112.26% | -61.60% | -135.29% | -42.52% | ||||||||||||||||||||||||||||||||
| EBIT Margin | -110.02% | -122.99% | -170.93% | -158.48% | -248.14% | -140.91% | -153.34% | -136.61% | -147.98% | -95.83% | -151.93% | -79.14% | -94.62% | -74.28% | -102.88% | -64.67% | -106.85% | -54.65% | -124.26% | -35.05% | ||||||||||||||||||||||||||||||||
| EBITDA Margin | -110.02% | -122.99% | -170.93% | -158.48% | -248.14% | -140.91% | -153.34% | -136.61% | -147.98% | -95.83% | -151.93% | -79.14% | -94.62% | -74.28% | -102.88% | -64.67% | -106.85% | -54.65% | -124.26% | -35.05% | ||||||||||||||||||||||||||||||||
| Operating Margin | -110.02% | -122.99% | -170.93% | -158.48% | -248.14% | -140.91% | -153.34% | -136.61% | -147.98% | -95.83% | -151.93% | -79.14% | -94.62% | -74.28% | -102.88% | -64.67% | -106.85% | -54.65% | -124.26% | -35.05% | ||||||||||||||||||||||||||||||||
| Net Margin | -89.41% | -149.65% | -190.55% | -177.03% | -270.23% | -150.13% | -163.16% | -147.57% | -162.82% | -97.17% | -156.83% | -89.51% | -95.71% | -81.51% | -108.63% | -68.86% | -112.81% | -2.20% | -136.03% | -42.99% | ||||||||||||||||||||||||||||||||
| FCF Margin | -98.24% | -84.41% | -187.28% | -121.08% | -133.83% | -113.51% | -181.00% | -120.12% | -123.98% | -67.19% | -178.20% | -53.71% | -49.19% | -53.13% | -120.14% | -67.07% | -57.67% | -48.61% | -145.59% | -45.79% | ||||||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 15.14M | 15.71M | 17.02M | 19.44M | 21.46M | 24.31M | 26.69M | 27.44M | 30.03M | 32.89M | 34.94M | 38.02M | 41.74M | 44.17M | 45.52M | 46.26M | 49.35M | 52.10M | 53.50M | 57.00M | ||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 1,498.62M | 1,503.60M | 1,453.21M | 1,352.33M | 1,469.55M | 1,581.96M | 1,464.42M | 1,347.36M | 1,274.72M | 1,364.58M | 1,399.05M | 1,462.76M | 1,578.40M | 1,520.68M | 1,407.46M | 1,309.10M | 1,248.36M | 1,361.22M | 1,414.00M | 1,280.00M | ||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.24 | 0.23 | 0.23 | 0.25 | 0.23 | 0.23 | 0.26 | 0.30 | 0.32 | 0.32 | 0.32 | 0.33 | 0.33 | 0.37 | 0.42 | 0.47 | 0.51 | 0.49 | 0.47 | 0.56 | ||||||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -10.35 | -26.96 | -20.75 | -23.40 | -15.52 | -9.17 | -9.86 | -9.62 | -8.21 | -7.03 | -10.43 | -7.29 | -8.40 | -7.90 | -10.21 | -7.71 | -12.08 | -5.82 | -8.05 | -3.41 | ||||||||||||||||||||||||||||||||
| Times Interest Earned | -10.35 | -26.96 | -20.75 | -23.40 | -15.52 | -9.17 | -9.86 | -9.62 | -8.21 | -7.03 | -10.43 | -7.29 | -8.40 | -7.90 | -10.21 | -7.71 | -12.08 | -5.82 | -8.05 | -3.41 | ||||||||||||||||||||||||||||||||
| Dividends & Payouts | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividend Coverage RatioDiv. Cover | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| FCF Payout RatioFCF Cover | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividend YieldDiv. Yield | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Payout Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -83.97 | -46.73 | -33.28 | -26.41 | -11.84 | -20.96 | -17.28 | -20.63 | -16.12 | -31.86 | -22.73 | -28.78 | -38.40 | -28.99 | -22.52 | -30.46 | -16.08 | -487.66 | -11.13 | -35.79 | ||||||||||||||||||||||||||||||||
| Price to SalesP/S | 75.07 | 69.93 | 63.41 | 46.75 | 31.99 | 31.47 | 28.19 | 30.44 | 26.24 | 30.96 | 35.65 | 25.76 | 36.76 | 23.63 | 24.46 | 20.98 | 18.14 | 10.72 | 15.14 | 15.38 | ||||||||||||||||||||||||||||||||
| Price to BookP/B | 6.56 | 6.32 | 6.36 | 6.16 | 6.19 | 9.24 | 12.85 | 25.55 | 81.13 | 14.31 | 27.66 | 8.76 | 14.78 | 15.26 | 23.61 | 23.20 | 316.74 | -27.77 | -8.73 | -11.31 | ||||||||||||||||||||||||||||||||
| Enterprise Value | 5,392.37M | 5,091.02M | 4,470.33M | 3,634.03M | 2,013.33M | 2,504.48M | 2,204.12M | 2,744.72M | 2,130.92M | 3,358.71M | 3,467.58M | 3,022.94M | 4,512.90M | 3,287.82M | 2,912.87M | 3,023.14M | 2,482.73M | 1,548.80M | 1,653.39M | 3,007.25M | ||||||||||||||||||||||||||||||||
| EV to EBIT | -60.03 | -49.64 | -32.72 | -25.67 | -8.95 | -17.20 | -14.30 | -18.55 | -14.69 | -27.57 | -20.97 | -25.98 | -34.19 | -26.88 | -20.37 | -27.99 | -14.53 | -13.67 | -9.78 | -40.10 | ||||||||||||||||||||||||||||||||
| EV to EBITDA | -60.03 | -49.64 | -32.72 | -25.67 | -8.95 | -17.20 | -14.30 | -18.55 | -14.69 | -27.57 | -20.97 | -25.98 | -34.19 | -26.88 | -20.37 | -27.99 | -14.53 | -13.67 | -9.78 | -40.10 | ||||||||||||||||||||||||||||||||
| Market Capitalization | 6,129.49M | 5,831.22M | 5,068.65M | 4,176.82M | 2,902.00M | 3,252.24M | 2,833.48M | 3,296.70M | 2,573.01M | 3,936.33M | 3,879.66M | 3,786.76M | 5,127.50M | 3,890.82M | 3,400.26M | 3,503.42M | 2,900.98M | 2,221.80M | 2,059.39M | 3,292.25M | ||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -76.42 | -82.84 | -33.86 | -38.61 | -23.91 | -27.72 | -15.58 | -25.34 | -21.17 | -46.08 | -20.00 | -47.95 | -74.73 | -44.48 | -20.36 | -31.28 | -31.45 | -22.05 | -10.40 | -33.59 | ||||||||||||||||||||||||||||||||
| EV to FCF | -67.23 | -72.32 | -29.86 | -33.59 | -16.59 | -21.35 | -12.12 | -21.10 | -17.53 | -39.31 | -17.88 | -38.28 | -65.77 | -37.58 | -17.44 | -26.99 | -26.92 | -15.37 | -8.35 | -30.69 | ||||||||||||||||||||||||||||||||
| EV to CFO | -90.40 | -93.68 | -38.04 | -47.04 | -21.12 | -27.72 | -14.05 | -23.63 | -18.08 | -39.94 | -18.18 | -39.28 | -67.36 | -41.45 | -17.55 | -27.74 | -27.23 | -15.51 | -8.39 | -31.00 | ||||||||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -110.02% | -122.99% | -170.93% | -158.48% | -248.14% | -140.91% | -153.34% | -136.61% | -147.98% | -95.83% | -151.93% | -79.14% | -94.62% | -74.28% | -102.88% | -64.67% | -106.85% | -54.65% | -124.26% | -35.05% | ||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -27.54% | -28.87% | -32.02% | -41.59% | -48.77% | -49.13% | -53.47% | -60.99% | -58.07% | -52.48% | -50.30% | -46.11% | -41.41% | -45.55% | -46.03% | -49.74% | -59.91% | -54.76% | -51.53% | -56.85% | ||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -24.00% | -30.35% | -32.52% | -37.58% | -46.30% | -44.93% | -49.33% | -53.74% | -50.10% | -44.48% | -43.87% | -40.03% | -35.44% | -37.48% | -39.10% | -40.77% | -46.51% | -33.13% | -34.30% | -36.09% |